DAVID V GOEDDEL

CIK 1182464 · last filed 2025-05-30

DAVID V GOEDDEL is a corporate insider who has filed 81 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for TNYA, was dated May 30, 2025. Across all open-market trades the lifetime net is +$305.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $41.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$41.73M

Companies

5

Total Filings

81

Lifetime Open-Market Net

$305.79M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNYA Director 4,985,570 $0.71 $3.55M $64.56M 12 2025-05-30
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Director 0 $1.54 $0 $97.10M 64 2024-04-08
RAPT Therapeutics, Inc. (RAPT) Delisted Director 1,402,171 $58.01 $81.34M $144.13M 3 2022-05-25
ORIC 10%+ Owner 4,616,666 $8.27 $38.18M $0 1 2020-04-28
Gritstone bio, Inc. (GRTS) Delisted 3,102,934 $0.03 $99.9K $0 1 2018-10-02

Recent Filings

81 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-05-30 TNYA Grant (A) $0 EDGAR
2025-03-07 TNYA Buy (P) +35,714,284 $25.00M EDGAR
2024-10-21 TNYA Grant (A) $0 EDGAR
2024-04-08 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Mixed −22,007,593 $0 EDGAR
2024-02-14 TNYA Buy (P) +2,222,222 $10.00M EDGAR
2023-11-17 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +26,811 $18.3K EDGAR
2023-06-12 TNYA Grant (A) $0 EDGAR
2023-05-12 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Grant (A) $0 EDGAR
2023-03-14 TNYA Buy (P) +6,779 $17.6K EDGAR
2023-02-10 TNYA Buy (P) +1,500,000 $3.90M EDGAR
Showing 110 of 81
Page 1 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.